Magdalena Chechlińska

1.1k total citations
38 papers, 790 citations indexed

About

Magdalena Chechlińska is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Magdalena Chechlińska has authored 38 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Magdalena Chechlińska's work include Lymphoma Diagnosis and Treatment (9 papers), Ovarian cancer diagnosis and treatment (5 papers) and MicroRNA in disease regulation (5 papers). Magdalena Chechlińska is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Ovarian cancer diagnosis and treatment (5 papers) and MicroRNA in disease regulation (5 papers). Magdalena Chechlińska collaborates with scholars based in Poland, Hungary and United States. Magdalena Chechlińska's co-authors include Magdalena Kowalewska, Radosława Nowak, Janina Kamińska, M Kowalska, Małgorzata Fuksiewicz, Jan Steffen, Beata Kotowicz, Maciej Głogowski, E. Wójcik and Jan Konrad Siwicki and has published in prestigious journals such as Nature reviews. Cancer, Blood and PLoS ONE.

In The Last Decade

Magdalena Chechlińska

37 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Chechlińska Poland 15 370 246 197 186 122 38 790
Miaoxia He China 16 311 0.8× 311 1.3× 173 0.9× 152 0.8× 299 2.5× 52 800
Stephanie Petrillo Canada 18 293 0.8× 394 1.6× 216 1.1× 94 0.5× 59 0.5× 38 794
Bin Meng China 18 334 0.9× 245 1.0× 141 0.7× 136 0.7× 151 1.2× 62 814
Sung‐Im Do South Korea 16 340 0.9× 399 1.6× 258 1.3× 84 0.5× 127 1.0× 84 913
Akihiro Ohmoto Japan 14 418 1.1× 158 0.6× 130 0.7× 62 0.3× 114 0.9× 75 706
Bridget Charbonneau United States 13 250 0.7× 200 0.8× 118 0.6× 237 1.3× 173 1.4× 17 795
Paolo Cotzia United States 17 363 1.0× 364 1.5× 272 1.4× 163 0.9× 133 1.1× 34 1.1k
Jürgen Tepel Germany 16 346 0.9× 203 0.8× 143 0.7× 140 0.8× 63 0.5× 23 823
Anne‐Laure Pointet France 7 721 1.9× 238 1.0× 200 1.0× 360 1.9× 115 0.9× 8 1.0k
Alessandra Bisagni Italy 16 285 0.8× 172 0.7× 124 0.6× 73 0.4× 134 1.1× 51 765

Countries citing papers authored by Magdalena Chechlińska

Since Specialization
Citations

This map shows the geographic impact of Magdalena Chechlińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Chechlińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Chechlińska more than expected).

Fields of papers citing papers by Magdalena Chechlińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Chechlińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Chechlińska. The network helps show where Magdalena Chechlińska may publish in the future.

Co-authorship network of co-authors of Magdalena Chechlińska

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Chechlińska. A scholar is included among the top collaborators of Magdalena Chechlińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Chechlińska. Magdalena Chechlińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Głogowski, Maciej, Magdalena Chechlińska, Natalia Żeber‐Lubecka, et al.. (2025). Persistent and novel changes in plasma microRNA profiles in patients with non-small cell lung cancer following tumour resection. Translational Lung Cancer Research. 14(3). 677–706. 1 indexed citations
2.
Szumera‐Ciećkiewicz, Anna, et al.. (2024). 3D modeling of normal skin and cutaneous squamous cell carcinoma. A comparative study in 2D cultures, spheroids, and 3D bioprinted systems. Biofabrication. 16(2). 25021–25021. 13 indexed citations
3.
Dansonka‐Mieszkowska, Agnieszka, Anna Stachurska, Piotr Sobiczewski, et al.. (2022). PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients. PLoS ONE. 17(7). e0271539–e0271539. 7 indexed citations
4.
Chechlińska, Magdalena, et al.. (2020). Genes, pathways and vulvar carcinoma - New insights from next-generation sequencing studies. Gynecologic Oncology. 158(2). 498–506. 17 indexed citations
5.
Zalewski, Kamil, et al.. (2018). Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective. Current Pharmaceutical Design. 24(15). 1652–1675. 13 indexed citations
6.
Rymkiewicz, Grzegorz, Beata Grygalewicz, Magdalena Chechlińska, et al.. (2018). A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Modern Pathology. 31(5). 732–743. 44 indexed citations
7.
Głogowski, Maciej, et al.. (2017). Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection. Cellular Oncology. 40(5). 529–536. 54 indexed citations
8.
Rymkiewicz, Grzegorz, Magdalena Chechlińska, Barbara Pieńkowska‐Grela, et al.. (2015). miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B–cell lymphoma. Tumor Biology. 36(7). 5377–5388. 17 indexed citations
9.
Kowalska, M, Magdalena Chechlińska, Małgorzata Fuksiewicz, et al.. (2012). Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biology. 33(5). 1733–1738. 7 indexed citations
10.
Chechlińska, Magdalena, Magdalena Kowalewska, Edyta Brzóska, et al.. (2010). Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma. Tumor Biology. 31(6). 559–567. 18 indexed citations
11.
Fuksiewicz, Małgorzata, M Kowalska, Beata Kotowicz, et al.. (2010). Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 48(10). 1481–1486. 18 indexed citations
12.
Kowalewska, Magdalena, Radosława Nowak, & Magdalena Chechlińska. (2010). Implications of cancer-associated systemic inflammation for biomarker studies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806(2). 163–171. 23 indexed citations
13.
Kowalska, M, Janina Kamińska, Małgorzata Fuksiewicz, et al.. (2009). A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival. Medical Oncology. 28(1). 194–198. 8 indexed citations
14.
Chechlińska, Magdalena, Magdalena Kowalewska, & Radosława Nowak. (2009). Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nature reviews. Cancer. 10(1). 2–3. 129 indexed citations
15.
Chechlińska, Magdalena, Jan Konrad Siwicki, Monika Goś, et al.. (2009). Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal. BMC Genomics. 10(1). 261–261. 11 indexed citations
16.
Chechlińska, Magdalena, M Kowalska, & Janina Kamińska. (2008). Cytokines as potential tumour markers. Expert Opinion on Medical Diagnostics. 2(6). 691–711. 15 indexed citations
17.
Kamińska, Janina, M Kowalska, Beata Kotowicz, et al.. (2006). Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis. Oncology. 70(2). 115–125. 104 indexed citations
18.
Kamińska, Janina, Marek P. Nowacki, M Kowalska, et al.. (2005). Clinical Significance of Serum Cytokine Measurements in Untreated Colorectal Cancer Patients: Soluble Tumor Necrosis Factor Receptor Type I – An Independent Prognostic Factor. Tumor Biology. 26(4). 186–194. 93 indexed citations
19.
Chechlińska, Magdalena. (2003). The role of cytokines in carcinogenesis. Nowotwory Journal of Oncology. 53(6). 648–648. 5 indexed citations
20.
Chechlińska, Magdalena, et al.. (1996). Interleukin-10 (IL-10), interleukin-1 receptor antagonist (IL-1ra) and soluble IL-2 receptor alpha (sIL-2Ra) in ascitic and cystic fluids from pat ients with malignant and benign ovarian tumours. Medical Science Monitor. 2(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miaoxia He Breakdown of academic impact, for papers by Stephanie Petrillo Breakdown of academic impact, for papers by Bin Meng Breakdown of academic impact, for papers by Sung‐Im Do Breakdown of academic impact, for papers by Akihiro Ohmoto Breakdown of academic impact, for papers by Bridget Charbonneau Breakdown of academic impact, for papers by Paolo Cotzia Breakdown of academic impact, for papers by Jürgen Tepel Breakdown of academic impact, for papers by Anne‐Laure Pointet Breakdown of academic impact, for papers by Alessandra Bisagni
Rankless by CCL
2026